Research
Diagnosed hypertension in Canada: incidence, prevalence and associated mortality
Cynthia Robitaille, Sulan Dai, Chris Waters, Lidia Loukine, Christina Bancej, Susan Quach, Joellyn Ellison, Norman Campbell, Karen Tu, Kim Reimer, Robin Walker, Mark Smith, Claudia Blais and Hude Quan
CMAJ January 10, 2012 184 (1) E49-E56; DOI: https://doi.org/10.1503/cmaj.101863
Cynthia Robitaille
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MScSulan Dai
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MD PhDChris Waters
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
BScLidia Loukine
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MScChristina Bancej
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
PhDSusan Quach
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MScJoellyn Ellison
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MPHNorman Campbell
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MDKaren Tu
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MD MScKim Reimer
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
BEd BScRobin Walker
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MScMark Smith
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MScClaudia Blais
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
PhDHude Quan
From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
MD PhDArticle Information
vol. 184 no. 1 E49-E56
PubMed
History
- Published online January 9, 2012.
Article Versions
- Latest version (November 21, 2011 - 08:21).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 Canadian Medical Association or its licensors
Author Information
- Cynthia Robitaille, MSc⇑,
- Sulan Dai, MD PhD,
- Chris Waters, BSc,
- Lidia Loukine, MSc,
- Christina Bancej, PhD,
- Susan Quach, MSc,
- Joellyn Ellison, MPH,
- Norman Campbell, MD,
- Karen Tu, MD MSc,
- Kim Reimer, BEd BSc,
- Robin Walker, MSc,
- Mark Smith, MSc,
- Claudia Blais, PhD,
- Hude Quan, MD PhD
- From the Chronic Disease Surveillance and Monitoring Division (Robitaille, Dai, Waters, Loukine, Bancej, Ellison), Public Health Agency of Canada, Ottawa, Ont.; Public Health Ontario (Quach), Toronto, Ont.; the University of Calgary (Campbell, Walker, Quan), Calgary, Alta.; the Institute for Clinical Evaluative Sciences (Tu), Toronto, Ont.; the British Columbia Ministry of Health Services (Reimer), Victoria, BC; the Manitoba Centre for Health Policy (Smith), Winnipeg, Man.; and the Institut national de santé publique du Québec and Faculté de pharmacie, Université Laval (Blais), Québec, Que.
- Correspondence to:
C. Robitaille, cynthia.robitaille{at}phac-aspc.gc.ca
Statistics from Altmetric.com
In this issue
Article tools
Respond to this article
Diagnosed hypertension in Canada: incidence, prevalence and associated mortality
Cynthia Robitaille, Sulan Dai, Chris Waters, Lidia Loukine, Christina Bancej, Susan Quach, Joellyn Ellison, Norman Campbell, Karen Tu, Kim Reimer, Robin Walker, Mark Smith, Claudia Blais, Hude Quan
CMAJ Jan 2012, 184 (1) E49-E56; DOI: 10.1503/cmaj.101863
Diagnosed hypertension in Canada: incidence, prevalence and associated mortality
Cynthia Robitaille, Sulan Dai, Chris Waters, Lidia Loukine, Christina Bancej, Susan Quach, Joellyn Ellison, Norman Campbell, Karen Tu, Kim Reimer, Robin Walker, Mark Smith, Claudia Blais, Hude Quan
CMAJ Jan 2012, 184 (1) E49-E56; DOI: 10.1503/cmaj.101863
Jump to section
Related Articles
Cited By...
- Effects of a Province-wide Triaging System for TIA: The ASPIRE Intervention
- The challenges of measuring blood pressure during COVID-19: How to integrate and support home blood pressure measurements
- Take urgent action diagnosing, treating, and controlling hypertension in older women
- Evaluation of a community paramedicine health promotion and lifestyle risk assessment program for older adults who live in social housing: a cluster randomized trial
- Physician follow-up and long-term use of evidence-based medication for patients with hypertension who were discharged from an emergency department: a prospective cohort study
- The Coming of Age of the Angiotensin Hypothesis in Alzheimers Disease: Progress Toward Disease Prevention and Treatment?
- Validation of two case definitions to identify pressure ulcers using hospital administrative data
- Association between neighbourhood walkability and metabolic risk factors influenced by physical activity: a cross-sectional study of adults in Toronto, Canada
- How do family physicians measure blood pressure in routine clinical practice?: National survey of Canadian family physicians
- Guiding the reporting of studies that use routinely collected health data
- Elevated BP after AKI
- Healthcare Costs Attributable to Hypertension: Canadian Population-Based Cohort Study
- Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION)
- Assessment and management of resistant hypertension
- Trends in Short- and Long-Term Survival Among Out-of-Hospital Cardiac Arrest Patients Alive at Hospital Arrival
- Systemic Autoimmune Rheumatic Disease Prevalence in Canada: Updated Analyses Across 7 Provinces
- The CANHEART health index: a tool for monitoring the cardiovascular health of the Canadian population
- Consumer attitudes and understanding of low-sodium claims on food: an analysis of healthy and hypertensive individuals
- Journee mondiale de la Sante: Sur le theme de l'hypertension en 2013
- World Health Day: Focusing on hypertension in 2013